等待开盘 12-20 09:30:00 美东时间
+0.030
+0.63%
An announcement from Abpro Holdings ( ($ABP) ) is now available. On December 15...
12-15 20:50
Abpro Holdings, a biotechnology company, received a Nasdaq extension to regain compliance with listing requirements. The company has reduced operating expenses by ~60% and completed a reverse stock split. It plans to increase shareholders’ equity via flexible financing and achieve long-term milestones. Lead candidate ABP-102 is on track for first-in-human trials in 2026. Abpro remains focused on executing its compliance plan while advancing its p...
12-09 12:00
Abpro Corporation (Nasdaq: ABP) ("Abpro") and Celltrion, Inc. ("Celltrion") today announced that they will present new preclinical data for CT-P72/ABP-102, a tetravalent bispecific antibody targeting HER2 and CD3, at the
11-04 22:17
Abpro Holdings, Inc. implemented a 1-for-30 reverse stock split to comply with Nasdaq listing standards and support future growth. The company reduced its operating costs by ~60% and is leveraging its DiversImmune® platform to enhance pipeline value. The reverse split reduced outstanding shares from 81.2 million to 2.7 million under the ticker symbol "ABP." Abpro aims to efficiently create long-term shareholder value through its leaner structure,...
11-03 12:00
On October 16, 2025, Abpro Holdings, Inc. (the "Company") filed with the Delaware Secretary of State a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Certificate of Amendment"), which
10-23 05:15
Maxim Group analyst Jason McCarthy downgrades Abpro Hldgs (NASDAQ:ABP) from Buy to Hold.
10-21 23:01
Gainers iBio (NASDAQ:IBIO) stock increased by 28.8% to $1.15 during Monday's a...
10-21 05:08
Abpro Holdings ( ($ABP) ) has issued an update. Abpro Holdings, Inc. is facing ...
10-18 04:49
中国质量新闻网讯 据上海市市场监督管理局网站消息,近期,上海市市场监督管理局对本市生产、销售的家用空调产品质量进行了监督抽查。本次抽查了20批次产品。经检验,未...
10-15 16:14